Treatment for Brain Metastases: ASCO-SNO-ASTRO GuidelineMichael A. Vogelbaum(Moffitt Cancer Center), David Schiff(University of Virginia Medical Center)Journal of Clinical OncologyDecember 21, 202110.1200/jco.21.02314Cited by 775SaveCiteExport RISWatch citationsRelated PapersA phase 1 and randomized, placebo‐controlled phase 2 trial of bevacizumab plus dasatinib in patients with recurrent glioblastoma: Alliance/North Central Cancer Treatment Group N0872|Cancer|2019|70